US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 17, 2021 (6 years ago)

Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50

Recalling firm
The General Hospital Corporation
NDC code
76318-334-50
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0288-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fludeoxyglucose recalls

See all